FDA says there is no proof ingredients in antibacterial soaps work

FDA Bans Antibacterial Chemicals in Soaps

Manufacturers had failed to show either the safety of “long-term daily use” or that the products were “more effective than plain soap and water in preventing illness and the spread of certain infections”.

The rule applies to products – such as liquid soaps, bar soaps and body washes – that contain one or more of 19 active ingredients, including the most commonly used, triclosan and triclocarban. In a 2014 news release, Johnson and Johnson pledged to remove triclosan from its consumer products by 2015 and now list it as one of the ingredients they don’t use.

The move is aimed at countering consumer perception that the antibacterial washes are more effective at killing germs and preventing illness, said the FDA’s Dr. Janet Woodcock. It does not affect alcohol-based hand sanitizers and wipes, which the FDA is still investigating, or certain healthcare products meant specifically for clinical settings.

The ruling is the FDA’s final say in an ongoing debate about whether triclosan and 18 other antimicrobial ingredients actually work and are safe to use. Manufacturers also haven’t proven if antibacterial soaps are more effective than their normal counterparts in preventing the spread of disease. Some manufacturers have already reportedly started removing the ingredients from their products.

“Washing the hands with an antiseptic soap can help reduce the risk of infection beyond that provided by washing with non-antibacterial soap and water”.

So, what can consumers use to replace antibacterial soaps?

The post ‘Antibacterial soap do more harm than good’ appeared first on Vanguard News. Soap companies have another year to prove the efficacy and safety of chemicals like benzalkonium chloride, benzethonium chloride and chloroxylenol, which are less common ingredients found in some varieties of antibacterials. Using these products might give people a false sense of security,”said Theresa M. Michele, of the FDA’s Division of Nonprescription Drug Products”. However, the FDA is reviewing those products separately.

In announcing the final rule Friday, the FDA said that manufacturers did not provide the necessary data for the 19 ingredients covered in the regulation.

“This whole issue of antibiotics, where they do good and they don’t do good, has not been explained well enough to the public, but I think it can be now”, said Levy, who conducted some of the earliest studies on antibiotic resistance. These products will no longer be sold under misleading marketing in the US.